The bacterial species in the Streptococcus anginosus group (S. constellatus, S. anginosus, S. intermedius) are important causative pathogens of bacterial pneumonia, pulmonary abscesses and empyema. However, the bacteria in this group are primarily oral resident bacteria and unable to grow significantly on ordinary aerobic culture media. We experienced a case of pneumonia and empyema caused by Streptococcus intermedius detected using a 16S rRNA gene sequencing analysis of bronchoalveolar lavage fluid and pleural effusion, but not sputum. Even when applying the molecular method, sputum samples are occasionally unsuitable for identifying the causative pathogens of lower respiratory tract infections.
Introduction
The significance of oral bacteria as pathogens in various types of respiratory infections has recently been reported (1) (2) (3) . In particular, it has been shown that members of the Streptococcus anginosus group (S. constellatus, S. anginous, S. intermedius), a Streptococcus spp. strain, are important causative pathogens of bacterial pneumonia, pulmonary abscesses and empyema (4) (5) (6) (7) . However, the bacteria in this group are oral bacteria and unable to grow significantly on ordinary aerobic culture media. Therefore, conventional cultivation may underestimate the role of these causative pathogens (4, 8) , and it is often difficult to evaluate the S. anginosus group as causative pathogens of respiratory infections in clinical practice.
We previously reported that clone library analyses of the 16S rRNA gene are useful for making a bacteriological diagnosis as a culture-independent method in patients with pneumonia and pleuritis (9, 10) . We herein report the case of a patient with pneumonia and empyema caused by S. intermedius that was successfully detected using a 16S rRNA gene sequencing analysis of bronchoalveolar lavage fluid and pleural effusion specimens.
Case Report
A 79-year-old Japanese man visited a local hospital due to a fever and productive cough in September 2012. He had stayed in a nursing home and had a medical history of surgical treatment of right empyema in May of that year. Chest computed tomography (CT) performed on admission to the hospital revealed new areas of infiltration in the left upper lobe with left thickened pleura accompanied by pleural effusion. The patient was referred to our hospital for further examinations. He had a history of smoking (20 cigarettes per day for 58 years) and had been an alcoholic drinker. He had dementia, but no other underlying diseases, including allergic diseases, or family history. On admission, the patient's blood pressure was 104/66 mmHg, his pulse was 118 beats/min, his transcutaneous saturation of oxygen was 93% (on nasal oxygen support of 3 L/min) and his body temperature was 38.4 . The patient's state of oral hygiene was poor; however, no apparent dental caries were recognized. Coarse crackles were audible in the left lung field. The laboratory findings on admission (Table 1) Based on these findings, the patient was diagnosed as having left pneumonia with empyema. Treatment with meropenem (MEPM, 1 g/day) was started, and left pleurectomy with chest drainage was performed on the second day of admission. A bronchoalveolar lavage (BALF) specimen and sputum sample were obtained from the left S 3 using fiberoptic bronchoscopy on admission before starting the administration of MEPM. Sputum cultivation identified only methicillin-sensitive Staphylococcus aureus (MSSA); however, cultivation of the BALF did not identify any causative pathogens using conventional cultivation methods. Meanwhile, cultivation of the left pleural effusion identified the Streptococcus anginosus group, which was sensitive to penicillin, cephem and carbapenem antibiotics, including meropenem. The bacterial composition in the BALF specimen was analyzed using a clone library of the 16S rRNA gene, as previously described (9, 10) . Briefly, DNA samples were extracted from the BALF specimens, and 580 partial base pairs of the 16S rRNA gene were amplified via polymerase chain reaction (PCR) using specific primer pairs. The PCR products were cloned with a TOPO TA cloning kit (Invitrogen; Carlsbad, USA), and clone libraries were constructed. Then, 96 clones were randomly chosen from each clone library, and the sequences of the 16S rRNA gene were determined. A homology search comparing the sequences with recorded basic strains was performed using the basic local alignment search tool (BLAST) algorithm.
The composition of the bacterial clones in the BALF specimens determined using this molecular method is shown in Table 2 . All of the 75 clones (100%) were identified to be Streptococcus intermedius. Similar results were obtained in the left pleural effusion (76 of 77 clones (98.7%) were similar to S. intermedius). In contrast, the molecular method analysis of the sputum primarily detected Staphylococcus aureus (24 of 58 clones (41.4%)), and only one of the 58 clones (1.7%) was S. intermedius ( Table 2 ). The left chest drainage was discontinued three days after surgery, and the patient's symptoms, laboratory and chest radiologic findings gradually improved. MEPM was discontinued 14 days after admission.
Discussion
In this case, a 16S rRNA gene sequencing analysis of BALF specimens obtained from the left lung and left pleural effusion was very useful for certifying the presence of S. intermedius. We previously reported the significance of anaerobes and oral bacteria in patients with community-acquired pneumonia and pleuritis (9, 10) . This molecular method can be used to identify pathogens that are generally difficult to cultivate using ordinary cultivation methods.
S. intermedius is a facultative aerobe that ordinarily colonizes the mouth and upper respiratory tract. Recent reports have shown S. intermedius to be an important pathogen in patients with respiratory infections (1-7) and a causative pathogen in 13-44% of pulmonary abscesses and/or cases of empyema (2, 4, 11) . On the other hand, S. intermedius accounts for only 2-5% of causative pathogens of bacterial pneumonia (3, 12) . Oral streptococci are not commonly considered pathogens using sputum cultivation; therefore, the pathogenic role of S. intermedius may be underestimated (4). In fact, S. intermedius is more frequently reported in studies using specimens other than sputum, such as specimens obtained with percutaneous lung needle aspiration or transthoracic needle aspiration (4, 8) .
In the present case, the molecular method in combination with cultivation revealed that S. intermedius was present in the BALF specimen and left pleural effusion. Therefore, S. intermedius was considered to be the causative pathogen of the patient's pneumonia and left empyema. The molecular method analysis of the BALF sample detected S. intermedius, despite the fact that cultivation of the BALF sample did not show any growth. Additionally, both cultivation and the molecular method analysis of the pleural effusion sample detected S. intermedius. The administration of MEPM was not initiated before sampling the sputum and pleural effu-sion samples, although MEPM was being administered at the time that the BALF sample was obtained; therefore, the bacteria in the bronchoalveolar lavage sample may not have been culturable due to MEPM administration, and the time at which the samples were obtained may explain this discrepancy.
Interestingly, the molecular analysis of the sputum showed that only one of the 58 clones (1.7%) was similar to S. intermedius and that 24 of the 58 clones (41.4%) were most similar to the S. aureus that was detected using cultivation. The patient met the criteria for nursing and health care-associated pneumonia (NHCAP) in Japan or health care-associated pneumonia (HCAP) in the United States, and MSSA is an important causative pathogen of NHCAP and HCAP. Based on the results of the present case, physicians should consider possible discrepancies between the results obtained via sputum cultivation and the actual causative pathogens.
In the present patient, other species, such as Fusobacterium sp. in the pleural effusion and Streptococcus pseudopneumonia in the sputum, were detected using the molecular method that were not identified using ordinary cultivation methods. Fusobacterium sp. are anaerobic pathogens, and we previously reported that Fusobacterium sp. are important anaerobic pathogens associated with empyema that are especially important in mixed infections (9) . On the other hand, S. pseudopneumonia belongs to the Streptococcus mitis group, and the significance of this bacterial phenotype in respiratory tract infections remains unclear. In our patient, S. pseudopneumonia was detected in the sputum sample. In a previous report, this bacterial phenotype was detected in a BALF sample. The report described that this phenotype may include not only respiratory tract colonization, but also pneumonia and bronchitis (13) . Therefore, in this case, we think that it is possible that the Fusobacterium sp. or S. pseudopneumonia may have caused a mixed infection with S. intermedius.
There is a limitation that should be considered when interpreting the results. The number of clones analyzed in this study was 96 clones per library, suggesting that this method may not be able to detect bacterial 16S rRNA gene sequences occupying very small fractions (less than 1% of each sample).
In conclusion, we herein presented a case of pneumonia and empyema caused by S. intermedius that was successfully detected using a clone library analysis of the 16S rRNA gene in addition to ordinary cultivation. We speculate that using cultivation-independent methods of detecting bacteria in sample lines would make the clinical role of this bacterial species in the pathogenesis of respiratory infections more clear. Even when applying the molecular method, sputum samples occasionally do not identify the causative pathogens of lower respiratory tract infections, and physicians should appreciate the clinical importance of the results of sputum samples in estimating the causative pathogens of pneumonia.
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